• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE SENSOR; EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE SENSOR; EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 101967-950
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Discomfort (2330); Skin Infection (4544)
Event Date 07/26/2023
Event Type  Injury  
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.A review of the device's manufacturing records revealed that the sensor lot met all requirements including sterilization requirements for release.The sensor is inserted by making a small incision and placing it under skin and potential for developing skin irritation/swelling/pain/ inflammation/infection around the insertion site is a known anticipated adverse event.The sensor was inserted on (b)(6) 2023.The customer first noticed symptoms (warmth, pus, and slight pain at the insertion site) on (b)(6) 2023 (day 67 of sensor life).The system asserted a sensor replacement alert and retired the sensor the next day, (b)(6) 2023.The customer scheduled an appointment for the same day to have the sensor removed and get a new sensor inserted.When the customer visited the hcp's office on (b)(6) 2023, the hcp examined the site and confirmed infection at the site of the retired sensor.The sensor was removed was inserted with another eversense e3 sensor.The customer is doing fine and does not have further issues.No further investigation was found necessary for this complaint.
 
Event Description
Senseonics was made aware of an incident where the patient's hcp observed and confirmed infection at the insertion site during the time of removal of the sensor, on (b)(6) 2023.The customer first noticed (experienced) the symptoms on (b)(6) 2023.The site of infection was hot and the patient had little pain and pus around the sensor.After the sensor was removed, the patient had no more pain and felt well.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE SENSOR
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown 20876-7005
MDR Report Key18117253
MDR Text Key327879836
Report Number3009862700-2023-00289
Device Sequence Number1
Product Code QHJ
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/11/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date06/23/2023
Device Model Number101967-950
Device Catalogue NumberFG-4500-50-302
Device Lot NumberWP08965
Was Device Available for Evaluation? No
Date Manufacturer Received09/13/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured07/07/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-